Clinical Trial

Gastrointestinal Response of Pediatric Cystic Fibrosis Patients on Mediterranean Diet

Study acronym: MedDietCF
Recruiting
View on ClinicalTrials.gov →
Summary
There is no study to date that has evaluated the impact or effect of a Mediterranean diet in children with CF. The goal of this study would be to help provide better guidance around questions the investigators, as CF care providers continue to receive from patients and families about how to best promote overall health in pediatric cystic fibrosis from a dietary perspective. Currently, the updated nutritional recommendations are variable and broad. Parents continue to search for more concrete guidance about how best to promote long-term health given the ever-increasing life expectancy of cystic fibrosis patients in this new area of advanced therapeutics. Given the changing landscape of the CF care in general, children are less likely to struggle with early life malnutrition, and it is becoming increasingly clear that high fat, high calorie diets are not beneficial nor are necessary for all children with CF.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-10-29; most recent amendment 2026-07-01.
Status change: Not Yet Recruiting → Recruiting 2026-04-30
Trial Details
NCT Number NCT07223255
Lead Sponsor Dartmouth-Hitchcock Medical Center
Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions Cystic Fibrosis (CF), Cystic Fibrosis Gastrointestinal Disease
Enrollment 20 participants
Start Date 2026-09-01
Primary Completion 2027-06 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2026-07-02